Skip Navigation

Link to  the National Institutes of Health  
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Archives of the National Institute on Drug Abuse web site
Go to the Home page
   

NIDA Home > Publications > Director's Reports > May, 2010 Index    

Director's Report to the National Advisory Council on Drug Abuse - May, 2010



Meetings/Conferences

NIDA convened the 8th Blending Conference on April 22-23, 2010, in Albuquerque, New Mexico in partnership with the University of New Mexico, the University of Arizona, and the University of California, San Francisco. The Conference, titled: Blending Addiction Science and Practice: Evidence-Based Treatment and Prevention in Diverse Populations and Settings, provided an opportunity for over 1,300 clinicians and researchers to collectively learn about innovative, science-based approaches that have been proven to be effective in the prevention and treatment of drug abuse and addiction. This two-day event has evolved into NIDA's signature conference and is designed to narrow the "translational gap" by disseminating science-based findings to treatment providers. The Blending Conference Planning Committee included NIDA's Deputy Director, Dr. Timothy P. Condon, who oversaw all conference planning activities, Drs. Cindy Miner (OSPC), Denise Pintello (OD), Carol Cushing and Harold Perl (CCTN), as well as Dr. Susan Storti and Roxanne Kibben, who worked closely with the two CTN Node PIs co-hosting the Blending Conference: Drs. James Sorenson (California-Arizona Node) and Michael Bogenschutz (Southwest Node).

The National CTN Steering Committee Meetings were held April 19-21, 2010 in conjunction with the NIDA Blending Conference in Albuquerque, New Mexico.

  • CTP and PI Caucuses
  • Invest Fellow Meeting
  • Executive Committee
  • Research Utilization Committee
  • Research Development Committee
  • Node Coordinator Workgroup
  • Steering Committee
  • CTN 10th Anniversary Symposium
  • Psychology Special Interest Group
  • Pharmacotherapy Special Interest Group
  • CTN 0015 Women's Treatment for Trauma and SUD
  • CTN 0037 STRIDE Study Team
  • CTN 0046 S-CAST Study Team
  • CTN 0047 SMART ED Study Team

On April 21, 2010, the CTN convened a Celebration and Symposium in Honor of the 10th Anniversary of the National Drug Abuse Treatment Clinical Trials Network. This celebrated 10 years of research and clinical trials in the CTN and focused both on past findings and potential future directions. The symposium included 3 panels on pharmacological research findings, psychosocial research findings, and the implications on clinical practice and policy yielded by the dissemination and implementation of CTN research findings. Six additional speakers addressed topics such as: the past, present, and future of the CTN following the original 1998 IOM report on "Bridging the Gap;" HIV/AIDS research; community expectations of CTN research; impact of psychological research; international collaborations; and smoking cessation research. The symposium concluded with closing remarks by Dr. Nora Volkow.

On January 13th and 14th, 2010 NIDA held a meeting entitled Exploring Interconnections: A Network Dynamics Workshop for Understanding and Preventing Adolescent and Young Adult Substance Abuse at Natcher Conference Center, Balcony B, and NIH Main Campus. The National Institutes on Drug Abuse (Co-chairs: Drs. Bethany Deeds, Elizabeth Ginexi and Thomas Brady) collaborated with the NIH's Office of Behavioral and Social Sciences Research (OBSSR), the Eunice Kennedy Shriver National Institute of Child Health and Development (NICHD) and the National Institute of Alcohol Abuse and Alcoholism (NIAAA) to develop and implement this successful workshop. The workshop's objectives were to describe state-of-the-art methodological advances in the field of social network research; identify and discuss obstacles and opportunities for stimulating and integrating scientific advancements in social network analysis for epidemiology, prevention, and services research in adolescents and young adult substance use; and discuss strategies for promoting the translation of social network research findings to improve prevention and treatment of substance use among adolescents and young adults, including the support of ongoing recovery.

On March 19, 2010 Drs. Jeff Schulden and Aria Crump of DESPR chaired a meeting entitled Drugged Driving: Future Research Directions to develop a research agenda for future efforts to reduce injuries and deaths related to drug impaired driving. This meeting involved private sector and federal participants including representatives from the National Highway Traffic Safety Administration, the Office of National Drug Control Policy, and the National Institute on Alcohol Abuse and Alcoholism.

Dr. Jonathan D. Pollock, DBNBR, organized and chaired the Consortium on the Genetic Analysis of Smoking Phenotypes (CGASP) meeting, held February 23, 2010 at the Inner Harbor Sheraton Hotel, Baltimore, MD. The Consortium on the Genetic Analysis of Smoking Phenotypes (CGASP) was established in June 2010 to conduct meta-analysis of the genetics of smoking phenotypes and to integrate primary genetic and phenotypic data on smoking phenotypes. The CGASP consortium has four analytic groups. These are analysis of ch15q125 for smoking phenotypes; a group for analyzing smoking initiation; a group for smoking cessation, and a group for biomarkers. Groups of investigators from more than 37 institutions participate in CGASP. As a result of this effort a manuscript describing a meta-analysis of smoking phenotypes associated with chr15q25 is in preparation.

On February 22-23, 2010, the Special Populations Office hosted a two-day Research Development Seminar Series workshop in Bethesda, Maryland. Chaired by Flair Lindsey, Program Analyst, the workshop was geared to trainee investigators interested in becoming funded through NIDA and the NIH. During the two-day session, trainee investigators met with funded NIDA investigators and senior NIDA program officials, received feedback on research concept papers and learned about the NIH grants submission and review processes.

On April 12-13, 2010, the Special Populations Office, in conjunction with the Association of Black Psychologists (ABPsi), hosted a two-day Research Development Seminar Series workshop in Bethesda, Maryland. Chaired by Flair Lindsey, Program Analyst, the workshop was attended by 15 trainee investigators interested in becoming funded through NIDA and the NIH. The workshop provided participants with an opportunity to meet with NIDA funded investigators and senior NIDA program officials, receive feedback on research concept papers, learn of NIDA/NIH program interests and priority areas and learn about the NIH grants submission and review processes.

CCTN staff organized a NIDA Science Meeting titled Clinically Meaningful Substance Abuse Treatment Outcome Measures for Effectiveness Trials. It was held on December 15-16, 2009, in Bethesda, MD, and was sponsored by NIDA's Office of Science Policy and Communications.


Dr. Timothy P. Condon, Deputy Director, NIDA, delivered the keynote presentation, "Addiction Fact & Fiction" and served as a panelist at the Writer's Guild of America West Panel on Addiction in Los Angeles, California on January 14, 2010.

Dr. Timothy P. Condon chaired the Blending Planning Meeting at the Hyatt Regency in Albuquerque, New Mexico on January 22, 2010.

Dr. Timothy P. Condon chaired the NIDA Meeting on Funding Scientists/Organizations that accept Tobacco Monies in Bethesda, Maryland on January 26, 2010.

Dr. Timothy P. Condon presented opening welcome remarks at the NIDA POP Workgroup cross-agency Workshop on Pain Measurement, Pain Measurement Scales: Current Issues and Future Direction in Bethesda, Maryland on January 27, 2010.

Dr. Timothy P. Condon participated as a panelist for the CADCA Federal Town Hall on Substance Use Disorders: Health and Healthcare Reform and co-chaired a workshop on "How to Implement Evidence-Based Prevention Programs that Work: Proven Examples to Use in Your Communities" in National Harbor, Maryland on February 9, 2010.

Dr. Timothy P. Condon co-chaired the Blending Team Meeting: MIEDAR 2.0 in Rockville, Maryland on February 23, 2010.

Dr. Timothy P. Condon moderated a panel discussing The Science of Addiction: How Science has Revolutionized the Understanding of Drug Addiction" at the US-Mexico Bi-National Drug Demand Reduction Policy Meeting at the U.S. State Department in Washington, D.C. on February 23, 2010.

Dr. Timothy P. Condon was an expert panelist at the Multijurisdictional Counterdrug Task Force Training broadcast taping in Saint Petersburg, Florida on February 26, 2010.

Dr. Timothy P. Condon spoke at the National Inhalant Prevention Coalition at the National Press Club in Washington, D.C. on March 11, 2010.

Dr. Timothy P. Condon presented a "National Institute on Drug Abuse: Institute Update" at the Washington Circle Expert Panel Meeting: Performance Measurement for Substance Use Disorders: A Research Agenda Meeting in Washington, DC on March 18, 2010.

Dr. Timothy P. Condon participated on a plenary panel at the TERROS 6th Annual Cesar Chavez Behavioral Health Conference "Overcoming Barriers of Health Disparities: Diversity, Civility, and Acceptance in Behavioral Health" at Arizona State University in Glendale, Arizona on March 26, 2010.

Dr. Timothy P. Condon presented and served as a panel chair for the "Dissemination/ Implementation & Policy/Practice Implications Panel" during the Celebration and Symposium in Honor of the 10th Anniversary of the National Drug Abuse Treatment Clinical Trials Network in Albuquerque, New Mexico on April 19, 2010.

Dr. Timothy P. Condon provided welcoming remarks at the NIDA Blending Conference in Albuquerque, New Mexico on April 22, 2010.

Dr. Cindy Miner, Deputy Director, OSPC, was the ÔScientist On-Site' at the DEA Museum's traveling exhibit Target America: Opening Eyes to the Damage Drugs Cause on March 2-3, 2010 in New Orleans, LA.

Dr. Susan Weiss, Chief, Science Policy Branch, OSPC gave a presentation as part of the DEA Museum Lecture Series on: The Science of Marijuana: What We Know and What We Don't on April 27, 2010.

Dr. Susan Weiss spoke at the IBRO Women in World Neuroscience Event at the Cosmos Club, Washington DC. The topic of her lecture was the Role of Stress in Drug Addiction on March 23, 2010.

Dr. Ruben Baler, Science Policy Branch, OSPC, lectured on "The Neuroscience of Addiction" in the Drug Awareness course at the George Washington School of Public Health on February 2, 2010.

Dr. Lula Beatty, Ph.D., Director, SPO, attended a meeting of the Office of Minority Health's (OMH) Federal Interagency Management Team on January 29, 2010 in Bethesda, Maryland.

Dr. Lula Beatty participated in the sixth annual National African American Drug Policy Coalition (NAADPC) Summit on March 24-26, 2010 in Silver Spring, Maryland.

Dr. Lula Beatty participated on an expert panel at SAMHSA on Treatment Improvement Protocols (TIPS) on March 3, 2010 in Rockville, Maryland.

Dr. Lula Beatty served as a moderator at meeting on African American Marriage and Health, which was sponsored by the Administration for Children and Families (ACF), DHHS, on March 4, 2010 at the Humphrey Building in Washington, D.C.

Dr. Lula Beatty served as Faculty at the Leadership Institute for Women in Psychology (LIWP) meeting on March 18, 2010 in Washington, D.C.

Dr. Lula Beatty attended a meeting of APA's Committee on Women and Psychology on March 19, 2010 in Washington, D.C.

Dr. Lula Beatty attended a meeting on NIH's Clinical Research Education and Career Development (CRECD) program, along with PIs and Program Officials, on April 5, 2010 in Bethesda, Maryland.

Dr. Lula Beatty was a keynote speaker at a conference on addiction at North Carolina A&T State University in Greensboro, North Carolina on April 16, 2010. Her keynote address was centered on Health Disparities and Culturally Based Treatment.

Ana Anders, M.S.W., Public Health Analyst, SPO, participated in the National Hispanic Science Network (NHSN) steering committee meeting on February 15-16, 2010 in Los Angeles, California.

Ana Anders participated in the National Hispanic Medical Association (NHMA) annual conference on March 26-27, 2010 in Washington, D.C.

Dr. Cora Lee Wetherington, DBNBR and Coordinator, Women and Sex/Gender Differences Research Program was an invited session co-chair (with Dace Svikis, VCU) of the paper session, "Sex and Tobacco Use," at the annual meeting of the Society for Research on Nicotine and Tobacco, February 24-27, 2010, Baltimore, MD.

Dr. Samia Noursi, DBNBR and Deputy Coordinator, Women and Sex/Gender Differences Research Program chaired three panel presentations as the National Summit on Interpersonal Violence and Abuse across the Lifespan: Forging A Shared Agenda, February 24-26, 2010, Dallas, TX. The first was a plenary presentation entitled "Intersecting Problems of HIV, Partner Abuse, and Trauma Among Drug-involved Women: Implications for Prevention and Treatment," by Dr. Nabila El- Bassel, Columbia University. The second panel entitled "Violence, Abuse, and Trauma: Are they Risk Factors for Drug Abuse" with the following speakers: Carolyn Smith Cynthia Larkby, and Laura Proctor. The third panel entitled "Gender Issues in Intimate Partner Violence," with Denise Hines, Maureen McHugh and Kenneth Leonard.

Dr. Da-Yu Wu, DBNBR, organized a web-based workshop on rat genetics and rat genomics research for drug addiction held on February 25. The meeting was co-chaired by Drs. Da-Yu Wu, Minda Lynch and Jonathan Pollock, with leading scientists invited nationally and internationally in the areas of behavioral genetics and rat and human genetic and genomics, and was attended by NIH staff from several institutes including NCI, NCRR and NIDA.

Dr. Cora Lee Wetherington represented NIDA at the IOM Neuroscience Forum's Workshop on Sex Differences and Implications for Translational Neuroscience Research in San Francisco, CA, March 8-9, 2010.

Dr. Roger Sorensen, DBNBR, participated in the Interagency Epilepsy Working Group (IEWG) meeting, hosted by the National Institute of Neurological Disorders and Stroke (NINDS) with representation from various federal and epilepsy affiliate agencies held on 23 March in Bethesda, MD.

Dr. Cora Lee Wetherington gave an invited Psychiatry Grand Rounds presentation, "Gender Differences in Drug Abuse," at the University of Miami Miller School of Medicine, March 26, 2010.

Dr. David Shurtleff, Director, DBNBR, gave an invited presentation "Overview of NIDA and NIH Research Funding Opportunities" at the 16th Annual Meeting of the Society on Neuroimmune Pharmacology, held on April 14-18 in Manhattan Beach, CA.

Dr. Yu (Woody) Lin, DCNBR, was invited by the Board of Directors to attend the 26th annual conference of the American Academy of Pain Medicine (AAPM) as a representative of the NIH Pain Consortium. The conference was held on February 4-6, 2010 in San Antonio, TX. Dr. Lin and Dr. David Thomas of DBNBR were introduced to AAPM Board of Directors, presented "an introduction to the NIH" at the AAPM research committee pre-meeting and served at the NIH booth.

Dr. Yu (Woody) Lin organized a seminar presented by Dr. Ajay Wasan of Brigham and Women's Hospital and Harvard Medical School entitled, The Impact of Negative Affect on Chronic Pain Treatment Outcomes, Including Prescription Opioid Misuse, sponsored by the Division of Clinical Neuroscience and Behavior Research held on January 26 at the NIH Neuroscience Building.

Dr. Yu (Woody) Lin participated in the organization of the 2010 Pain Consortium Symposium on "Moving Towards Personalized Pain Management" held on the NIH campus on May 5, 2010.

Dr. Steven Grant, DCNBR, presented a talk on "Translation of Addiction Neuroscience" as part of the 2010 University of Utah Brain Institute March Symposium series. The symposium was held at the University of Utah in Salt Lake City on March 19, 2010.

Dr. Steven Grant represented NIDA at the Dept. of Energy Radiochemistry and Radionuclide Imaging Instrumentation Program Contractor-Grantee Workshop that was held in Rockville, MD on January 5-6, 2010.

Dr. Steven Grant represented NIDA at a conference on Science-Policy-Practice in Addiction: Implications of Policy Work in Early Brain Development & Children's Mental Health for Addiction Research & Policy sponsored by the Norlien Foundation that was held on March 2, 2010 in Washington, DC.

Dr. Wilson M. Compton, Director, DESPR, served as Co-Chair for the Surveillance Subcommittee of the Department of Health and Human Services Tobacco Strategic Planning Workgroup, December, 2009 through March 2010 and ongoing.

Dr. Wilson M. Compton continues to participate in the DSM-V Task Force and DSM-V Substance Use Disorders Workgroup meetings on a continuing basis.

Dr. Wilson M. Compton presented on "Understanding Addiction as a Brain Disease: Implications for Recovery" at the Mississippi Society of Addiction Medicine, Jackson, Mississippi, January 15, 2010.

Dr. Wilson M. Compton participates in the ONDCP Inter-agency Workgroup for Demand Reduction; meetings have been held on an ongoing basis since March 2009.

Dr. Wilson M. Compton served as discussant and participant in the NIDA-sponsored meeting "Exploring Interconnections: A Network Dynamics Workshop for Understanding and Preventing Adolescent and Young Adult Substance Abuse", Bethesda, Maryland, January 13-14, 2010.

Dr. Wilson M. Compton presented on "Understanding Addiction as a Brain Disease: Implications for the Drug-Crime Nexus" at the New York Society of Psychiatry and the Law, New York, New York, January 23, 2010.

Drs. Elizabeth Robertson, Augie Diana and Jacqueline Lloyd of the Prevention Research Branch, DESPR, were on the planning committee for and attended the Phase II SPF SIG Cross-Site Evaluation Kick-Off Meeting on January 7, 2010 at the Westat Conference Center in Rockville, MD.

Drs. Elizabeth Robertson and Aleta Meyer, DESPR, attended a working meeting of the Society for Prevention Research, Type 2 Translational Research Task Force held at The Dupont Hotel in Washington, DC on February 18 -19, 2010.

Dr. Eve Reider, DESPR, represented NIDA as a member of the program planning committee for the 2nd Annual Trauma Spectrum Disorders Conference: A Scientific Conference on the Impact of Military Service on Families and Caregivers. This meeting was held December 10-11, 2009, Natcher Auditorium, NIH, Bethesda, MD.

Dr. Aleta Meyer chaired a session titled "Challenges with Adaptation and Fidelity when Translating Evidence-Based Practices" at the 10th Annual Scientific Meeting of the American Academy of Health Behavior on February 10, 2010, in Clearwater Beach, FL. The title of Dr. Meyer's talk was "Thinking about Adoption, Implementation, and Sustainability on the Front-end of Drug Abuse Prevention Research." Her co-presenter was Dr. Karen BlasŽ of the University of North Carolina-Chapel Hill.

Dr. Belinda Sims, in the Prevention Research Branch, DESPR, co-chaired a session with Dr. Timothy Condon, Deputy Director, NIDA titled "How to Implement Evidence-Based Prevention Programs That Work: Proven Examples to Use in Your Communities" at the 2010 CADCA National Leadership Forum, in National Harbor, MD, on February 9, 2010 Workshop speakers included Dr. Sheppard Kellam, American Institutes for Research, "Improving Behavior in 1st and 2nd Grade Classrooms: One of a Set of Prevention Strategies Over the Life Course"; Dr. Richard Spoth, Iowa State University, "PROSPER'S Formula for Achieving Positive Community-Level Outcomes"; and Dr. David Hawkins, University of Washington, "Coalitions Using The Communities That Care System to Prevent Drug Misuse and Crime Community-Wide."

Drs. Jacqueline Lloyd, Belinda Sims, and Aria Crump served as mentors for the NIDA Special Populations Office Research Development Seminar Series held in Bethesda on February 22 and 23, 2010. At this meeting, Dr. Crump also presented to the group on research priorities in DESPR.

On March 13, 2010 Dr. Aria Crump chaired two sessions for the Biennial Meeting of the Society for Research on Adolescence held in Philadelphia. The first session was entitled "Prevention of Drug Use and Problem Behavior in Adolescence: Considering the Cultural Context" and the second was entitled "Drug Use during the Transition to Adulthood: Predictors and Prevention in College Students."

Dr. Augusto Diana organized a symposium as part of the CSAP-NIDA Innovations in Prevention Symposium Series in Rockville, MD, February 4, 2010. The speaker was Dr. William Crano, who discussed his NIDA-funded research on the role of persuasion in preventing adolescent drug use.

Drs. Joe Frascella and Laurence Stanford represented NIDA at a conference on Science-Policy-Practice in Addiction: Implications of Policy Work in Early Brain Development & Children's Mental Health for Addiction Research & Policy sponsored by the Norlien Foundation that was held on March 2, 2010 in Washington, DC.

On March 5th 2010, Dr. Lisa Onken gave a presentation to the NIH Behavioral and Social Science Coordinating Committee entitled, "Behavioral Intervention Development: A Bidirectional + Translational Research Process to Develop Potent Interventions where Efficacy = Effectiveness."

Dr. Lisa Onken gave a plenary presentation, Behavioral Treatment Development: Efficacy, Effectiveness, and Community-Friendliness, at the International Conference on the Treatment of Addictive Behaviors in Santa Fe, New Mexico on February 10, 2010. The theme of the international conference was "Evidence-Based Treatment in Real World Systems: Maximizing Service, Value, and Outcome."

Dr. Lisa Onken led a "Roundtable" discussion on Everything You Want to Know about Behavior Therapy Development Grants at the International Conference on the Treatment of Addictive Behaviors in Santa Fe, New Mexico on February 10, 2010.

Dr. Shoshana Kahana and other members of the Behavioral and Integrative Treatment Branch, with Jacques Normand and Lynda Erinoff of NIDA's Office of AIDS Research, organized a 1.5 day meeting (March 4-5, 2010) on the Intersection of Technology, HAART Adherence, and Drug Abuse Treatment whose purpose was to encourage multidisciplinary collaboration between social scientists, medical researchers (doctors and nurses), and technology experts to develop and refine mobile technological instrumentation, e-health technology, and software as interventions to foster adherence to HIV treatment regimens and access to care among substance-abusing populations.

Drs. Jessica Chambers, Cecelia Spitznas, Lisa Onken, and Vince Smeriglio, all of DCNBR, held a NIDA-sponsored meeting on Digital Media & Communication Technologies in Adolescent Drug Abuse Treatment on April 26-27, 2010 in Rockville, MD. A major purpose was to encourage and facilitate research on the integration of digital media and communication technologies into adolescent drug abuse treatment.

Dr. Karen Sirocco, DCNBR, presented a grant-writing workshop at the International Neuropsychological Society, February 5, 2010 in Acapulco, Mexico.

Dr. Nicolette Borek and Dr. Cheryl Anne Boyce, DCNBR, participated in scientific sessions, workshops and technical assistance office hours at the Society for Research on Adolescence Biennial Meeting, March 11-12, 2010 in Philadelphia, PA, along with fellow colleagues Dr. Belinda Sims, Dr. LeShawndra Price, Dr. Aleta Meyer, and Dr. Jacqueline Lloyd, DESPR.

Dr. Ivan Montoya, DPMCDA, gave a lecture on March 26th at the Howard University's Annual Spring Institute (Washington DC) on the topic of Prevalence, Pharmacotherapies and Future Research on Marijuana Addiction.

Dr. Ivan Montoya presented a Webcast to the Department of Psychiatry of the University of Massachusetts entitled "Trends in Pharmacotherapy Research for Drug Addiction".

Dr. Jag Khalsa, DPMCDA, chaired a symposium on: Clinical Implications of Research on Genetics of Drug Addiction at the Annual Meeting of ASAM, April 14-18, 2010. Dr. Khalsa also co-chaired two additional symposia: "The Multiple Seen and Unseen Implications of the Criminal Justice System for Addiction Services" with Dr. Richard Denisco of DESPR, and "Alternatives to Conventional Treatment: A Joint Session with the International Society of Addiction Medicine" with Dr. Marc Galanter of ASAM.

Dr. Teri Levitin, Director, OEA, helped plan and participated in a workshop on grant writing for early career investigators that was held at the Society for Research on Adolescence meeting in Philadelphia in early March. Representatives from several ICs and NSF were on the panel.

Dr. Scott Chen, OEA, presented "Overview of the NIH Peer Review Process and Electronic Submission", NIDA Special Populations Research Development Seminar Series workshop with the Association of Black Psychologists at the Bethesda Doubletree Hotel, Bethesda, Maryland, April 13, 2010.

Dr. Gerald McLaughlin, OEA, presented an education and professional development session entitled "What's New at NIH? An Update on NIH Grants and Contracts Submission Processes." to the National Contract Management Association (NCMA) Bethesda Chapter on February 17, 2010.

Dr. Kristen Huntley, OEA, presented "NIH Training Grants and the Review Process" and co-chaired a workshop titled "Writing a Competitive Training Grant" at the Society for Research on Nicotine and Tobacco, 16th Annual Meeting, Baltimore, MD, February 26, 2010.

Dr. Gerald McLaughlin served as Judge for the Georgetown University School of Medicine graduate schoolÔs 24th annual Student Research Days Competition, March 16, 2010.

On February 9, 2010, Dr. Harold Perl, CCTN, co-chaired a symposium entitled, "Maximizing the Impact of Evidence-Based Treatment through Mutually Beneficial Collaborative Research with AI/AN Communities," and he presented a talk entitled, "Developing the NIDA CTN MOD Projects" at the Twelfth International Conference on Treating Addictive Behaviors in Santa Fe, NM.

Dr. Betty Tai, Director, CCTN, participated in the US-Mexico Bi-National Drug Demand Reduction Policy Meeting at the George Marshall Conference Center, U.S. Department of State February 23-25, 2010 in Washington, DC. She was the U.S. facilitator for one of the breakout sessions: Panel A - Collaborative Research Activities in Treatment and Prevention. Dr. José Szapocznik, Principal Investigator of the Florida Node, was the U.S. speaker for this session.

Dr. Amy Newman, IRP, was invited to participate in a panel entitled "Dopamine Signaling and Disease: Wormholes, Flytraps, Organic Farmers and Mouseketeers in the Pursuit of New Medications" at the 43rd Winter Conference on Brain Research, Breckinridge, CO, in January.

Dr. Amy Newman chaired the Plenary Symposium entitled "Dopamine D3 Receptors and Addiction" and gave the first talk entitled "Evolution of D3 Antagonists" at the Behavior, Biology and Chemistry: Translational Research in Addiction meeting, San Antonio, TX, in March 2010.

Several IRP scientists were members of a workshop at the 2010 Motivational Neuronal Network Conference, April 24-27, 2010, North Carolina. Dr. Roy Wise was a member of a workshop entitled "Extending the circuit, part 1: reemerging regions of the so-called, limbic system: the bed n. of the stria terminalis, extended amygdala, and the hypothalamus" and Dr. Thomas Jhou was a member of a workshop entitled "Extending the circuit, part 2: the emerging caudal areas, the lateral habenula, the PPTG, LDTG, and RMTG network in disappointment and pleasure".


Index

Research Findings

Program Activities

Extramural Policy and Review Activities

Congressional Affairs

International Activities

Meetings and Conferences

Media and Education Activities

Planned Meetings

Publications

Staff Highlights

Grantee Honors



Archive Home | Accessibility | Privacy | FOIA (NIH) | Current NIDA Home Page
National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. . The U.S. government's official web portal